These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 28801381)

  • 1. Fluoroquinolone Resistance Mechanisms by Molecular Epidemiologic Study of Ciprofloxacin-Nonsusceptible
    Yang HS; Kim Y; Cho SY; Nam YS; Oh TS; Park KS; Kim HC; Lee HJ
    Ann Clin Lab Sci; 2017 Aug; 47(4):511-515. PubMed ID: 28801381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of plasmid-mediated quinolone resistance determinants among Escherichia coli isolated from food animals in Korea.
    Tamang MD; Nam HM; Chae MH; Kim SR; Gurung M; Jang GC; Jung SC; Lim SK
    Foodborne Pathog Dis; 2012 Dec; 9(12):1057-63. PubMed ID: 23186547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diverse phenotypic and genotypic characterization among clinical Klebsiella pneumoniae and Escherichia coli isolates carrying plasmid-mediated quinolone resistance determinants.
    Yang J; Luo Y; Cui S; Wang W; Han L
    Microb Drug Resist; 2011 Sep; 17(3):363-7. PubMed ID: 21563956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and characteristics of Escherichia coli sequence type 131 and its H30 and H30Rx subclones: a multicenter study from Korea.
    Kim SY; Park YJ; Johnson JR; Yu JK; Kim YK; Kim YS
    Diagn Microbiol Infect Dis; 2016 Feb; 84(2):97-101. PubMed ID: 26643062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular epidemiology and genetic diversity of fluoroquinolone-resistant Escherichia coli isolates from patients with community-onset infections in 30 Chinese county hospitals.
    Zhao L; Zhang J; Zheng B; Wei Z; Shen P; Li S; Li L; Xiao Y
    J Clin Microbiol; 2015 Mar; 53(3):766-70. PubMed ID: 25520451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of plasmid-mediated quinolone resistance and mutations in the gyrase and topoisomerase IV genes in Salmonella isolated from 12 tertiary-care hospitals in Korea.
    Jeong HS; Kim JA; Shin JH; Chang CL; Jeong J; Cho JH; Kim MN; Kim S; Kim YR; Lee CH; Lee K; Lee MA; Lee WG; Shin JH; Lee JN
    Microb Drug Resist; 2011 Dec; 17(4):551-7. PubMed ID: 21830947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High prevalence of ST131 among CTX-M-producing Escherichia coli from community-acquired infections, in the Czech Republic.
    Papagiannitsis CC; Študentová V; Jakubů V; Španělová P; Urbášková P; Žemličková H; Hrabák J
    Microb Drug Resist; 2015 Feb; 21(1):74-84. PubMed ID: 25188031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of fluoroquinolone-resistant Escherichia coli O25:H4-ST131 (CTX-M-15-nonproducing) strains isolated in Japan.
    Yokota S; Sato T; Okubo T; Ohkoshi Y; Okabayashi T; Kuwahara O; Tamura Y; Fujii N
    Chemotherapy; 2012; 58(1):52-9. PubMed ID: 22343392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ciprofloxacin-resistant Escherichia coli in Central Greece: mechanisms of resistance and molecular identification.
    Mavroidi A; Miriagou V; Liakopoulos A; Tzelepi Ε; Stefos A; Dalekos GN; Petinaki E
    BMC Infect Dis; 2012 Dec; 12():371. PubMed ID: 23259844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of plasmid-mediated AmpC β-lactamase-producing Escherichia coli and spread of the ST131 clone among extended-spectrum β-lactamase-producing E. coli in Japan.
    Matsumura Y; Yamamoto M; Higuchi T; Komori T; Tsuboi F; Hayashi A; Sugimoto Y; Hotta G; Matsushima A; Nagao M; Takakura S; Ichiyama S
    Int J Antimicrob Agents; 2012 Aug; 40(2):158-62. PubMed ID: 22743014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Geographic distribution of fluoroquinolone-resistant Escherichia coli strains in Asia.
    Uchida Y; Mochimaru T; Morokuma Y; Kiyosuke M; Fujise M; Eto F; Harada Y; Kadowaki M; Shimono N; Kang D
    Int J Antimicrob Agents; 2010 Apr; 35(4):387-91. PubMed ID: 20138480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of Quinolone Resistance of Extended-Spectrum β-Lactamase-Producing
    Teramae M; Osawa K; Shigemura K; Kitagawa K; Shirakawa T; Fujisawa M; Miyara T
    Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31635210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intensity and Mechanisms of Fluoroquinolone Resistance within the H30 and H30Rx Subclones of Escherichia coli Sequence Type 131 Compared with Other Fluoroquinolone-Resistant E. coli.
    Johnson JR; Johnston B; Kuskowski MA; Sokurenko EV; Tchesnokova V
    Antimicrob Agents Chemother; 2015 Aug; 59(8):4471-80. PubMed ID: 25987621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of ST131 and ST1193 Among Bloodstream Isolates of Escherichia coli not Susceptible to Ciprofloxacin in a Tertiary Care University Hospital in Korea, 2013 - 2014.
    Kim Y; Oh T; Nam YS; Cho SY; Lee HJ
    Clin Lab; 2017 Sep; 63(9):1541-1543. PubMed ID: 28879712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of Inhibitor-Resistant TEM β-Lactamases and Mechanisms of Fluoroquinolone Resistance in Escherichia coli Isolates.
    Ríos E; López MC; Rodríguez-Avial I; Pena I; Picazo JJ
    Microb Drug Resist; 2015 Oct; 21(5):512-5. PubMed ID: 25945693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissemination of ST131 and ST393 community-onset, ciprofloxacin-resistant Escherichia coli clones causing urinary tract infections in Korea.
    Lee MY; Choi HJ; Choi JY; Song M; Song Y; Kim SW; Chang HH; Jung SI; Kim YS; Ki HK; Son JS; Kwon KT; Heo ST; Yeom JS; Shin SY; Chung DR; Peck KR; Song JH; Ko KS
    J Infect; 2010 Feb; 60(2):146-53. PubMed ID: 19932131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of mutation distribution in DNA gyrase and topoisomerase IV genes in ciprofloxacin-non-susceptible Enterobacteriaceae isolated from blood cultures in a tertiary care university hospital in South Korea, 2005-2010.
    Nam YS; Cho SY; Yang HY; Park KS; Jang JH; Kim YT; Jeong JW; Suh JT; Lee HJ
    Int J Antimicrob Agents; 2013 Feb; 41(2):126-9. PubMed ID: 23265914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations in DNA Gyrase and Topoisomerase IV in Ciprofloxacin-Nonsusceptible Extended-Spectrum -Lactamase-Producing Escherichia coli and Klebsiella pneumoniae.
    Park KS; Yang HS; Nam YS; Lee HJ
    Clin Lab; 2017 Mar; 63(3):535-541. PubMed ID: 28271673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution of fluoroquinolone resistance determinants in Carbapenem-resistant Klebsiella pneumoniae clinical isolates associated with bloodstream infections in China.
    Zhan Q; Xu Y; Wang B; Yu J; Shen X; Liu L; Cao X; Guo Y; Yu F
    BMC Microbiol; 2021 Jun; 21(1):164. PubMed ID: 34078263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasmid-mediated resistance to cephalosporins and fluoroquinolones in various Escherichia coli sequence types isolated from rooks wintering in Europe.
    Jamborova I; Dolejska M; Vojtech J; Guenther S; Uricariu R; Drozdowska J; Papousek I; Pasekova K; Meissner W; Hordowski J; Cizek A; Literak I
    Appl Environ Microbiol; 2015 Jan; 81(2):648-57. PubMed ID: 25381245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.